Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) Prescription Drug User Fee Act (PDUFA) goal date set for April 03,…Original Article
Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole
